LUKAS Pierre

Pittie, G., LUKAS, P., MASSART, M., Cavalier, E., & Le Goff, C. (2023). Evaluation of analytical and clinical performance of the AFIAS Tn-I plus assay -a new point-of-care. Acta Cardiologica, 1-7. doi:10.1080/00015385.2023.2286423

Cavalier, E., Farre Segura, J., LUKAS, P., GENDEBIEN, A.-S., Peeters, S., Massonnet, P., Le Goff, C., Bouquegneau, A., Souberbielle, J.-C., Delatour, V., & Delanaye, P. (2023). Unveiling a new era with liquid chromatography coupled with mass spectrometry to enhance parathyroid hormone measurement in patients with chronic kidney disease. Kidney International. doi:10.1016/j.kint.2023.09.033

Farre Segura, J., Le Goff, C., LUKAS, P., Cobraiville, G., Fillet, M., Servais, A.-C., Delanaye, P., & Cavalier, E. (03 November 2022). Validation of an LC-MS/MS Method Using Solid-Phase Extraction for the Quantification of 1-84 Parathyroid Hormone: Toward a Candidate Reference Measurement Procedure. Clinical Chemistry, 68 (11), 1399-1409. doi:10.1093/clinchem/hvac135

Castiglione, V., Berodes, M., LUKAS, P., Louis, E., Cavalier, E., & Lutteri, L. (27 September 2022). New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method. Diagnostics, 12 (10), 2338. doi:10.3390/diagnostics12102338

Farre Segura, J., COBRAIVILLE, G., LUKAS, P., LE GOFF, C., Servais, A.-C., Fillet, M., DELANAYE, P., & CAVALIER, E. (11 April 2022). Development and validation of a candidate reference method for 1-84 PTH by LC-MS/MS [Poster presentation]. EuroMedLab 2021 Munich, Munich, Germany.

Sempos, C. T., Williams, E. L., Carter, G. D., Jones, J., Camara, J. E., Burdette, C. Q., Hahm, G., Nalin, F., Duewer, D. L., Kuszak, A. J., Merkel, J., Hoofnagle, A. N., LUKAS, P., Cavalier, E., Durazo-Arvizu, R. A., Crump, P. M., Popp, C., Beckert, C., Schultess, J., ... Wise, S. A. (2022). Assessment of serum total 25-hydroxyvitamin D assays for Vitamin D External Quality Assessment Scheme (DEQAS) materials distributed at ambient and frozen conditions. Analytical and Bioanalytical Chemistry. doi:10.1007/s00216-021-03742-5

Cavalier, E., LUKAS, P., & DELANAYE, P. (2022). Analytical evaluation of the Nittobo Medical tartrate resistant acid phosphatase isoform 5b (TRACP-5b) EIA and comparison with IDS iSYS in different clinically defined populations. Clinical Chemistry and Laboratory Medicine, 60 (3), 394-400. doi:10.1515/cclm-2021-1190

Wise, S. A., Camara, J. E., Burdette, C. Q., Hahm, G., Nalin, F., Kuszak, A. J., Merkel, J., Durazo-Arvizu, R. A., Williams, E. L., Hoofnagle, A. N., Ivison, F., Fischer, R., van den Ouweland, J. M. W., Ho, C. S., Law, E. W. K., Simard, J.-N., Gonthier, R., Holmquist, B., Meadows, S., ... Sempos, C. T. (January 2022). Interlaboratory comparison of 25-hydroxyvitamin D assays: Vitamin D Standardization Program (VDSP) Intercomparison Study 2 - Part 1 liquid chromatography - tandem mass spectrometry (LC-MS/MS) assays - impact of 3-epi-25-hydroxyvitamin D(3) on assay performance. Analytical and Bioanalytical Chemistry, 414 (1), 333-349. doi:10.1007/s00216-021-03576-1

CASTIGLIONE, V., CAVALIER, E., LUTTERI, L., LUKAS, P., & BERODES, M. (19 November 2021). NEW FAECAL CALPROTECTIN ASSAY BY IDS: VALIDATION AND COMPARISON TO DIASORIN METHOD [Paper presentation]. RBSLM Annual Meeting, Brussels, Belgium.

Wise, S. A., Camara, J. E., Sempos, C. T., LUKAS, P., Le Goff, C., PEETERS, S., Burdette, C. Q., Nalin, F., Hahm, G., Durazo-Arvizu, R. A., Kuszak, A. J., Merkel, J., & Cavalier, E. (September 2021). Vitamin D Standardization Program (VDSP) Intralaboratory Study for the Assessment of 25-Hydroxyvitamin D Assay Variability and Bias. The Journal of steroid biochemistry and molecular biology, 212, 105917. doi:10.1016/j.jsbmb.2021.105917

Camara, J. E., Wise, S. A., Hoofnagle, A. N., Williams, E. L., Carter, G. D., Jones, J., Burdette, C. Q., Hahm, G., Nalin, F., Kuszak, A. J., Merkel, J., Durazo-Arvizu, R. A., LUKAS, P., Cavalier, E., Popp, C., Beckert, C., Schultess, J., Van Slooten, G., Tourneur, C., ... Sempos, C. T. (August 2021). Assessment of serum total 25-hydroxyvitamin D assay commutability of Standard Reference Materials and College of American Pathologists Accuracy-Based Vitamin D (ABVD) Scheme and Vitamin D External Quality Assessment Scheme (DEQAS) materials: Vitamin D Standardization Program (VDSP) Commutability Study 2. Analytical and Bioanalytical Chemistry, 413 (20), 5067-5084. doi:10.1007/s00216-021-03470-w

Cavalier, E., Fraser, C. G., Bhattoa, H. P., Heijboer, A. C., Makris, K., Ulmer, C. Z., Vesper, H. W., Vasikaran, S., LUKAS, P., DELANAYE, P., Carobene, A., & On Behalf Of The Ifcc-Iof Committee For Bone Metabolism. (January 2021). Analytical Performance Specifications for 25-Hydroxyvitamin D Examinations. Nutrients, 13 (2). doi:10.3390/nu13020431

Wise, S. A., Camara, J. E., Burdette, C. Q., Hahm, G., Nalin, F., Kuszak, A. J., Merkel, J., Durazo-Arvizu, R. A., Williams, E. L., Popp, C., Beckert, C., Schultess, J., Van Slooten, G., Tourneur, C., Pease, C., Kaul, R., Villarreal, A., Batista, M. C., Pham, H., ... Sempos, C. T. (2021). Interlaboratory comparison of 25-hydroxyvitamin D assays: Vitamin D Standardization Program (VDSP) Intercomparison Study 2 - Part 2 ligand binding assays - impact of 25-hydroxyvitamin D(2) and 24R,25-dihydroxyvitamin D(3) on assay performance. Analytical and Bioanalytical Chemistry. doi:10.1007/s00216-021-03577-0

Schoneveld, L., LUKAS, P., CAVALIER, E., & GADISSEUR, R. (20 November 2020). CA19.9 assays provide clinically different results for the patients [Poster presentation]. 2020 Annual Royal Belgian Society of Laboratory Medicine Meeting.

Schoneveld, L., LUKAS, P., CAVALIER, E., & GADISSEUR, R. (20 November 2020). CA19.9 assays provide clinically different results for the patients [Paper presentation]. 2020 Annual Royal Belgian Society of Laboratory Medicine Meeting.

CAVALIER, E., LUKAS, P., Warling, X., Moonen, M., Smelten, N., & DELANAYE, P. (2020). The percentage of non-oxidized PTH concentration remains stable over a period of 1 year in hemodialyzed patients. Clinica Chimica Acta, 506, 107-109. doi:10.1016/j.cca.2020.03.025

Cavalier, E., LUKAS, P., Bottani, M., Aarsand, A. K., Ceriotti, F., Coşkun, A., Díaz-Garzón, J., Fernàndez-Calle, P., Guerra, E., Locatelli, M., Sandberg, S., Carobene, A., Åkesson, K., Bhattoa, H. P., Bruyère, O., Cooper, C., Eastell, R., Garnero, P., Heijboer, A., ... on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine Working Group on Biological Variation and IOF-IFCC Committee on Bone Metabolism. (2020). European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein—a cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism. Osteoporosis International, 31 (8), 1461-1470. doi:10.1007/s00198-020-05362-8

VRANKEN, L., BERTHOLET, C., LUKAS, P., & CAVALIER, E. (15 November 2019). Comparison of two automated assays for the determination of cobalaminin serum [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019.

VRANKEN, L., FONTAINE, C., LUKAS, P., & CAVALIER, E. (15 November 2019). Unexpected high levels of Cobalamin (Vitamin B12). Is PEG treatment useful? [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019.

VRANKEN, L., FONTAINE, C., VALDES SOCIN, H. G., LUKAS, P., LE GOFF, C., Huyghebaert, L., & CAVALIER, E. (15 November 2019). Impact of Metformin on vitamin B12 status [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019.

CASTIGLIONE, V., Pottel, H., Lieske, J. C., LUKAS, P., CAVALIER, E., DELANAYE, P., & Rule, A. (2019). Evaluation of inactive Matrix-Gla-Protein (MGP) as a biomarker for incident and recurrent kidney stones. Journal of Nephrology. doi:10.1007/s40620-019-00623-0

GADISSEUR, R., LUKAS, P., & Cavalier, E. (03 June 2019). Phleum pratense may be taken as a marker allergen for Gx3 grass mix. Allergy, 74 (106), 101-331.

GADISSEUR, R., LUKAS, P., & Cavalier, E. (03 June 2019). Betula verrucosa may be taken as a marker allergen for Tx5 tree mix. Allergy, 74 (106), 130-331.

Bouchard-Lovighi, G., Veillet, A., Tsoumperi, D., Pages, J., Favre, C., Brossault, L., Dromenq, L., Tessonneau, M., Mougin, B., Priolo, G., Martinasso, G., Mengozzi, G., LUKAS, P., & CAVALIER, E. (June 2019). VIDAS PTH(1-84) ASSAY: Reference limits and comparison with three other third generation PTH assays. Clinica Chimica Acta, 493 (Supplement 1), 331.

LE GOFF, C., BECKERS, P., LUKAS, P., NIX, C., PEETERS, S., & CAVALIER, E. (21 May 2019). The new Diasorin Androstenedione immunoassay: analytical performances,comparison with a LC-MS/MS and establishment of the reference range values [Poster presentation]. Euromedlab, Barcelone, Spain.

VRANKEN, L., FONTAINE, C., LUKAS, P., LE GOFF, C., Huyghebaert, L., CAVALIER, E., & VALDES SOCIN, H. G. (May 2019). Evaluation of Metformin impact on vitamin B12 status [Poster presentation]. 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Barcelona 2019, Barcelone, Spain.

VRANKEN, L., FONTAINE, C., LUKAS, P., & CAVALIER, E. (May 2019). Unexpected high levels of Cobalamin(Vitamin B12). Is PEG treatment a solution? [Poster presentation]. 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Barcelona 2019.

VRANKEN, L., BERTHOLET, C., LUKAS, P., & CAVALIER, E. (May 2019). Comparison of two automated assays for the determination of cobalamin in serum. Which one to choose? [Poster presentation]. 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Barcelona 2019.

Le Goff, C., LUKAS, P., NIX, C., GENDEBIEN, A.-S., Fabregat Cabello, N., Peeters, S., & Cavalier, E. (2019). 17-hydroxyprogesterone : validation of a LC-MS/MS method and comparison with the new immunoassay IDS-iSYS 17-OH Progesterone [Poster presentation]. Euromedlab 2019.

Castiglione, V., DELANAYE, P., LUKAS, P., & CAVALIER, E. (19 October 2018). Matrix-Gla-Protein: un nouveau marqueur de lithiase urinaire? [Paper presentation]. 23e Confrontations Clinico-Biologiques sur la Lithiase Urinaire, Paris, France.

Libon, F., Courtois, J., LE GOFF, C., LUKAS, P., Fabregat Cabello, N., SEIDEL, L., Cavalier, E., & NIKKELS, A. (2017). Sunscreens block cutaneous vitamin D production with only a minimal effect on circulating 25-hydroxyvitamin D. Archives of Osteoporosis. doi:10.1007/s11657-017-0361-0

Courtois, J., BERTHOLET, C., LUKAS, P., Cavalier, E., Gillard, N., Tollenaere, S., Quinting, B., & GADISSEUR, R. (26 April 2017). Allergie au froment : caractérisation de nouveaux allergènes par immunoblot 2D et spectrométrie de masse [Poster presentation]. Congrès Francophone d'Allergologie, Paris, France. doi:10.1016/j.reval.2017.02.052

Cavalier, E., LUKAS, P., BEKAERT, A.-C., CARLISI, I., Le Goff, C., DELANAYE, P., & Souberbielle, J.-C. (March 2017). Analytical and clinical validation of the new Abbot Architect 25(OH)D assay: fit for purpose? Clinical Chemistry and Laboratory Medicine, 55 (3), 378-384. doi:10.1515/cclm-2016-0566

Libon, F., Courtois, J., LE GOFF, C., LUKAS, P., Fabregat Cabello, N., SEIDEL, L., CAVALIER, E., Reginster, J.-Y., & NIKKELS, A. (March 2017). Effect of body surface, body site and sunscreen application on production of Vitamin D and 25-hydroxyvitamin D after a single narrowband UVB exposure. Osteoporosis International, 28 Suppl 1, 143-144.

Libon, F., COURTOIS, J., Le Goff, C., LUKAS, P., Fabregat Cabello, N., SEIDEL, L., Cavalier, E., & Nikkels, A. (2017). Effect of Body Site and Surface on Vitamin D and 25-Hydroxyvitamin D Production after a Single Narrowband UVB Exposure. Journal of Investigative Dermatology, 137 (6), 1391-1393. doi:10.1016/j.jid.2017.01.032

Courtois, J., GADISSEUR, R., BERTHOLET, C., LUKAS, P., Cavalier, E., Gillard, N., & Quinting, B. (15 October 2016). Hunting for new wheat allergens : a 2D Immunoblot and mass spectrometry approach [Poster presentation]. 4th Food Allergy and Anaphylaxis meeting, Rome, Italy.

CAVALIER, E., LUKAS, P., BEKAERT, A.-C., PEETERS, S., LE GOFF, C., Yayo, E., DELANAYE, P., & Souberbielle, J.-C. (2016). Analytical and clinical evaluation of the new Fujirebio Lumipulse G non-competitive assay for 25(OH)-vitamin D and three immunoassays for 25(OH)D in healthy subjects, osteoporotic patients, third trimester pregnant women, healthy African subjects, hemodialyzed and intensive care patients. Clinical Chemistry and Laboratory Medicine. doi:10.1515/cclm-2015-0923

Libon, F., Courtois, J., LUKAS, P., LE GOFF, C., SEIDEL, L., CAVALIER, E., & NIKKELS, A. (October 2015). Effect of body surface, body site and sunscreen application on production of vitamin D and 25-hydroxyvitamin D after a single narrowband-UVB exposure [Paper presentation]. EADV Congress, Cophenhague, Denmark.

ROUSSEAU, A.-F., DAMAS, P., LEDOUX, D., LUKAS, P., CARLISI, I., LE GOFF, C., GADISSEUR, R., & CAVALIER, E. (August 2015). Vitamin D status after a high dose of cholecalciferol in healthy and burn subjects. Burns: Journal of the International Society for Burn Injuries, 41 (5), 1028-1034. doi:10.1016/j.burns.2014.11.011

DELANAYE, P., DUBOIS, B., LUKAS, P., PETERS, P., KRZESINSKI, J.-M., Pottel, H., & CAVALIER, E. (2015). impact of stopping vitamin K antagonist therapy on concentrations of dephospho-uncarboxylated Matrix Gla protein [letter to the editor]. Clinical Chemistry and Laboratory Medicine, 53 (8), 191-193. doi:10.1515/cclm-2015-0073

CAVALIER, E., BEKAERT, A.-C., LUKAS, P., PEETERS, S., GADISSEUR, R., LE GOFF, C., & DELANAYE, P. (October 2014). Les résultats des formules de calcul de la 25(OH)-vitamine D libre varient en fonction des méthodes de dosage de la 25(OH)D [Poster presentation]. 16ème Réunion commune - Société de néphrologie - Société de dialyse, Saint-Etienne, France.

CAVALIER, E., DUBOIS, B., BEKAERT, A.-C., LUKAS, P., PEETERS, S., GADISSEUR, R., LE GOFF, C., KRZESINSKI, J.-M., & DELANAYE, P. (October 2014). La membrane de dialyse peut-elle avoir une influence sur le statut en vitamine D du patient? [Poster presentation]. 16ème réunion commune - Société de néphrologie - Société de dialyse, Saint Etienne, France.

CAVALIER, E., DELANAYE, P., LUKAS, P., CARLISI, I., GADISSEUR, R., & Souberbielle, J.-C. (01 August 2014). Standardization of DiaSorin and Roche automated third generation PTH assays with an international standard: impact on clinical populations. Clinical Chemistry and Laboratory Medicine, 52 (8), 1137-41. doi:10.1515/cclm-2013-1027

CAVALIER, E., LUKAS, P., CRINE, Y., PEETERS, S., CARLISI, I., LE GOFF, C., GADISSEUR, R., DELANAYE, P., & Souberbielle, J.-C. (20 April 2014). Evaluation of automated immunoassays for 25 (OH)-vitamin D determination in different critical populations before and after standardization of the assays. Clinica Chimica Acta, 431, 60-5. doi:10.1016/j.cca.2014.01.026

CAVALIER, E., LUKAS, P., CRINE, Y., PEETERS, S., CARLISI, I., LE GOFF, C., GADISSEUR, R., DELANAYE, P., & Souberbielle, J.-C. (April 2014). Standardization of 25-hydroxyvitamin D assays: impact of vitamin-D binding protein concentrations and uremic media on the re-standardization of six different 25(OH) vitamin D immunoassays [Poster presentation]. WCO-IOF-ESCEO Seville 2014 : World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases, Séville, Spain.

ROUSSEAU, A.-F., DAMAS, P., LEDOUX, D., CARLISI, I., LUKAS, P., GADISSEUR, R., & CAVALIER, E. (2014). Vitamin D status during acute phase of burn injury : is 25(OH)D measurement an accurate marker ? Nutrients, 6, 2770.

DELANAYE, P., DUBOIS, B., LUKAS, P., PETERS, P., KRZESINSKI, J.-M., & CAVALIER, E. (2014). Impact of the stopping of vitamin K antagonist treatment on concentrations of Dephosphorylated and uncarboxylated Matrix Gla protein [Poster presentation]. ASN Kidney Week, Philadelphia, United States - Pennsylvania.

CAVALIER, E., LUKAS, P., CARLISI, I., GADISSEUR, R., & DELANAYE, P. (October 2013). Aminoterminal propeptide of type I procollagen (P1NP) in chronic kidney disease patients: the assay matters [letter to the editor]. Clinica Chimica Acta, 425, 117-118.

GADISSEUR, R., LUKAS, P., CARLISI, I., & CAVALIER, E. (July 2013). Analytical performance of the IDS-iSYS N-Mid osteocalcin immunoassay [Poster presentation]. AACC Annual meeting 2013, Houston, United States.

CAVALIER, E., LUKAS, P., CARLISI, I., & Souberbielle, J.-C. (July 2013). Standardization of 25-hydroxyvitamin D assays: impact of vitamin-D binding protein concentrations and uremic media on the restandarization of six different 25 (OH) vitamin D immunoassays [Poster presentation]. AACC Annual meeting 2013, Houston, United States.

GADISSEUR, R., LUKAS, P., CARLISI, I., & CAVALIER, E. (July 2013). Performance of the IDS-iSYS 1,25-dihydroxy vitamin D assay [Poster presentation]. AACC Annual meeting, Houston, United States.

GADISSEUR, R., LUKAS, P., CARLISI, I., & CAVALIER, E. (May 2013). Evaluation of the performance of the new automated IDS-ISYS 1,25-dihydroxy vitamin D assay. Biochimica Clinica, 37 (SS), 498.

CAVALIER, E., GADISSEUR, R., LUKAS, P., CARLISI, I., & DELANAYE, P. (May 2013). Association of the circulating inactive form of matrix GLA protein (DP-UCMGP) levels and abdominal aortic calcification score (AACS) in haemodialysis patients. Biochimica Clinica, 37 (SS), 215.

CAVALIER, E., LUKAS, P., FERRANTE, N., ROUSSELLE, O., CARLISI, I., & DELANAYE, P. (May 2013). Difference between total and intact assays for N-Terminal propeptide of type I procollagen (P1NP) determination in renal impaired patients. Biochimica Clinica, 37 (SS), 498.

LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on phosphocalcic metabolism biomarkers in healthy adults subjects. Osteoporosis International, 24 (S1), 282.

LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on bone biomarkers in healthy dults subjects. Osteoporosis International, 24 (S1), 329.

LAURENT, T., LUKAS, P., ROUSSELLE, O., FERRANTE, N., CARLISI, I., GADISSEUR, R., & CAVALIER, E. (April 2013). Effect of a single oral loading dose of 100,000 IU of cholecalciferol on serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations in healthy subjects. Osteoporosis International, 24 (S1), 279.

LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., Souberbielle, J.-C., & CAVALIER, E. (November 2012). Evaluation of the cross-reactivity of 25-hydroxyvitamin D2 on seven commercial immunoassays on native samples. Clinical Chemistry and Laboratory Medicine, 50 (11), 2031-2. doi:10.1515/cclm-2012-0164

LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., CHAPELLE, J.-P., & CAVALIER, E. (17 July 2012). Analytical validation of the Perkin-Elmer MSMS Vit D for 25-Hydroxy-vitamin D determination on AB SCIEX TQ5500 [Poster presentation]. AACC 2012, Los Angeles, United States.

LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., CHAPELLE, J.-P., & CAVALIER, E. (17 July 2012). Evaluation of the Cross-reactivity of 25-Hydroxy-vitamin D2 on Six Commercial Immunoassays on Native Samples [Poster presentation]. AACC 2012, Los Angeles, United States.

FORTUNATO, A., LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., ROUSSELLE, O., FERRANTE, N., & CAVALIER, E. (May 2012). Cross-reactivity of 25-hydroxyvitamin D2 in ADVIA Centaur Total Vitamin D [Poster presentation]. The joint 15th International Congress of Endocrinology and 14th European Congress of Endocrinoly, Florence, Italy.